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Summary 
The most important findings presented in this Ph.D. thesis are the following: 
1.) Almokalant, cibenzoline and chronic amiodarone treatment significantly lengthened 
the effective refracter period (ERP) at 1 Hz stimulation frequency. Chronic amiodarone 
administration depressed impulse conduction only at stimulation frequencies higher than 1 Hz 
which effect was intensified by faster stimulation. In contrast, cibenzoline depressed impulse 
conduction also at normal and slow heart rate, which effect may have harmful consequences by 
increaseing proarrhythmic risk. Cibenzoline markedly reduced the ERP shortening effect of 
cromakalim, indicating inhibition of the ATP-sensitive potassium channels that play an 
important role during cardiac ischaemia. 
2.) Desethylamiodarone possesses significant acute electrophysiological effects, which 
are different in cardiac Purkinje and ventricular muscle fibers and similar to those observed 
earlier with the parent compound amiodarone. Despite its lack of iodinated substituents, 
dronedarone, a novel derivative of amiodarone, exerts similar acute electrophysiological effects 
to those of amiodarone, and this finding could account for its promising role in the treatment 
of ventricular arrhythmias. 
3.) Ambasilide, a new investigational antiarrhythmic agent, in addition to its Class III 
antiarrhythmic effect which is characterized by the lack of reverse use-dependence, possesses 
also IB type antiarrhythmic properties. These actions of ambasilide are similar to those of 
amiodarone and suggest that because of its advantageous, ,/nultifaced" electrophysiological 
profile, this agent may be a promising drug candidate for antiarrhythmic therapy. 
4.) The existence of M cells in the canine left ventricle described earlier was confirmed. 
Important differences in some action potential parameters of M cells were revealed, namely the 
distribution of the maximal rate of depolarization and action potential amplitude values 
reflecting probably the inhomogeneity of the fast sodium current in these cells. It was 
demonstrated that M cells differ from Purkinje fibers in some aspects which were not obvious 
from previous investigations; 1. the early portion of the action potential duration (APD) 
restitution curve in M cells is more similar to that of endocardial and epicardial cells than to 
Purkinje fibers, 2. the potential range of the plateau phase in the M cell action potential is also 
more similar to that of endocardial and epicardial cells than to Purkinje fibers, 3. the 
pharmacological response of M cells to tetrodotoxin and pinacidil resembles more that of the 
endocardial and epicardial cells than the effect of these agents on Purkinje fibers. 
5.) Comparing the effects of two recently developped selective blockers of the slow 
component (1^) of Ik to those produced by two recognized selective blockers of the rapid 
component (Ikt) on normal dog ventricular muscle and Purkinje fiber action potential 
repolarization, it was found that in contrast to specific Ikt bolckers, specific inhibitors of Iks do 
not lengthen APD in either type of cardiac tissues. However, when APD is abnormally 
lengthened by other means, the effect of selective IKS blockers on repolarization increases 
substantially resulting in an excessive prolongation of the ventricular muscle APD. 
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1. Introduction 
Cardiac arrhythmias represent a major problem in clinical practice: for example, atrial 
fibrillation affects 1 million patients, and ventricular fibrillation, which is the most common 
cause of sudden cardiac death (in 70 to 80% of cases), kills 400,000 people every year in the 
USA alone (1). Accordingly, cardiac arrhythmias represent a major area of cardiovascular 
research. Drug therapy has traditionally been the mainstay of treatment for both ventricular 
and supraventricular arrhythmias. Nevertheless, serious side effects may considerably limit the 
use of several antiarrhythmic agents. Ventricular fibrillation was well recognized as being the 
primary cause of sudden cardiac death as early as in the early twentieth century (2), and in a 
classical series of experiments it was shown that ventricular fibrillation can be induced by 
critically timed electrical stimuli (3). This led to the "electrical accident" theory of sudden 
death, according to which premature ventricular contractions (PVCs) falling in a critical phase 
of the cardiac cycle induce ventricular fibrillation and thereby sudden death. In concordance 
with these findings, through the 1970's, antiarrhythmic drug development focused on the 
development of more effective oral agents for the suppression of PVCs, as quantified by 24-
hour ambulatory Holter monitoring. This effort culminated in the development of two highly-
effective class IC agents, encainide and flecainide, in the early 80's (4,5). The Cardiac 
Arrhythmia Suppression Trial (CAST) (6) was designed to confirm the ability of PVC-
suppressing class IC drugs to prevent sudden death in post-myocardial infarction patients with 
frequent PVCs. CAST was terminated prematurely when it was shown that the treatment 
group had a significant excess in mortality, due largely to an increase in the incidence of 
sudden death (7). This result was unexpected and shocking, and motivated a fundamental 
réévaluation of the strategy of drug treatment in ventricular tachyarrhythmias. Initially, the 
negative outcome of CAST was thought to reflect the particular properties of the CAST 
population, however, a subsequent analysis of controlled studies of quinidine in atrial 
fibrillation also pointed to mortality promotion in the relatively less sick atrial fibrillation 
population (7). Before the outcome of these results, the vast majority of antiarrhythmic 
compounds abolished arrhythmia by a mechanism of slowing or blocking impulse conduction 
due to a depression of the fast inward sodium current. These studies, however, underscored 
the importance of the proarrhythmic effects of Class I antiarrhythmic drugs and as a 
consequence, interest has been significantly lost in them. The disaffection with Class I drugs 
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for the prevention of sudden death has led the pharmaceutical industry to attempt to develop 
other agents, such as Class III compounds, that selectively prolong myocardial refractoriness 
without slowing intracardiac conduction, and at present, class III antiarrhythmic agents are 
favoured increasingly to treat patients with serious tachycardias. The use of the dextro-isomer 
of sotalol, which is a pure Class HI compound, was tested in postinfarction patients with left 
ventricular dysfunction in the SWORD (Survival With Oral d-Sotalol) trial (8). Despite the 
favourable antiarrhythmic effect, however, also this trial was stopped prematurely because 
patients on d-sotalol demonstrated a statistically significant increased mortality and sudden 
death risk. The adverse effect of the drug on mortality could be due to its bradycardia-
dependent proarrhythmic ("torsadogemc") effect, and most other pure Class ID compounds 
might have a similar harmful effect. The outcome of SWORD had a great impact on the 
development of new antiarrhythmic drugs. Numerous pure Class i n compounds under 
investigation have been discontinued from clinical development (9). Emphasis has therefore 
been shifting to the compounds with a multifaceted ("hybrid") pharmacological profile (10,11) 
(with multiple molecular targets in the framework of the Sicilian Gambit (12). Many 
investigators now believe that the ideal antiarrhythmic drugs for the future should share the 
complex profile of amiodarone, which is regarded nowadays as the most effective drug 
available for cardiac rhythm disturbances, exhibiting a uniquely complex spectrum of 
electropharmacological actions, with properties of all four antiarrhythmic classes (13). 
Accordingly, development of such drugs is expected to offer favourable new options for 
antiarrhythmic drug therapy. 
In accordance with the above, one of the goals of my PH.D. project was to investigate the 
cellular electrophysiological mechanisms of various antiarrhythmic drugs that act by 
lengthening the cardiac repolarization (notably cibenzoline, almokalant, amiodarone, 
desethylamiodarone, dronedarone, ambasilide, d-sotalol, E-4031, chromanol 293B, L-735,821) 
in isolated dog right ventricular papillary muscle and Purkinje fibers. Particular attention has 
been paid to their antiarrhythmic and proarrhythmic properties, rate dependence over a wide 
range of stimulation frequencies, the impact of their selectivity profile on their rate-dependent 
characteristics and finally their restitution kinetics. 
Differential diagnosis of cardiac arrhythmias requires an understanding of basic 
mechanisms and establishment of mechanism-specific electrophysiological criteria. Both in turn 
depend on our knowledge of the basic electrophysiological characteristics of the cells and 
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tissues of the heart and the extent to which heterogeneity or specialisation exists. Our ability to 
design specific drug treatments also depends on our understanding and awareness of 
differences in the pharmacological responsiveness of diverse cell types within the heart. Until 
recently, the ventricular muscle, which constitutes the vast majority of the mammalian heart, 
was thought to be relatively homogeneous with respect to electrophysiological and 
pharmacological properties. This might have been related to the fact that most of the 
electrophysiological and pharmacological knowledge concerning the ventricular myocardium 
stemmed from studies using endocardial preparations and Purkinje fibers, which are specialized 
for impulse conduction. Data obtained from endocardium were often generalized and 
considered to be representative of the ventricular myocardium as a whole. Recent studies, 
however, have revealed important regional differences in the electrophysiology and 
pharmacology of the ventricular myocardium in mammalian hearts (14,15) and provided data 
indicative of the existence of at least four functionally distinct cell types in the ventricles, 
including epicardial, midmyocardial (M), endocardial and Purkinje cells. The midmyocardial or 
M cells, an electrophysiological^ distinct population of cells in the deep subepicardial to 
midmyocardial layers of the canine ventricular free wall, were identified by Sicouri and 
Antzelevitch (16), and due to their longer repolarization characteristics they were found to 
have a significant role in creating enhanced dispersion of repolarization in the ventricular wall, 
thereby contributing importantly to arrhythmogenesis, in particular to intramural reentry and 
triggered activity. The characterization of the M cells in the ventricular wall of different 
mammalian species has prompted a réévaluation of some existing concepts relating to the 
electrophysiology, pharmacology and pathophysiology of the ventricles of the heart. Since the 
electrophysiological and pharmacological properties of M cells have not been fully elucidated, 
another major goal of my work was to provide further in vitro characterization of the existing 
differences among the four tissue types of the dog ventricle over a wide range of stimulation 
cycle lengths, and furthermore, to compare the pharmacological response of these cell types to 
different compounds, in the first instance to the sodium channel blocker tetrodotoxin, the 
calcium channel blocker nifedipine and the ATP-sensitive potassium channel activator pinacidil. 
Since the majority of studies thus far available on this topic suggest that M cells bear 
outstanding resemblance with Purkinje fibers and share only minor similarities with ventricular 
muscle fibers in the epicardium and endocardium, the focus of the investigations was set 
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especially on the electrophysiological and pharmacological differences between midmyocardial 
and Purkinje cells of the canine ventricle. 
The delayed rectifier potassium current (IK) is one of the most important 
transmembrane ionic currents controlling repolarization in mammalian ventricular muscle (17). 
In most species IK consists of two components, IKT (rapid) and IKS (slow). These two 
components differ from each other with respect to their drug sensitivity, rectification and 
kinetic properties (18). The relative small density of Irs was proposed to be the main reason for 
the longer repolarization observed in M cells relative to epicardial and endocardial cells (19). 
Specific blockers of IKT have been widely shown to lengthen cardiac action potential duration 
(APD) and this is consistent with their strong antiarrhythmic potency. Despite their favourable 
antiarrhythmic effect, however, the already mentioned SWORD study (8) revealed an increased 
mortality in patients treated with the IKT blocking antiarrhythmic drug d-sotalol. The reason is 
complex, but the following features of these drugs must be involved in the failure. First, pure 
Class III drugs (i.e. those that block IRT selectively) increase the inhomogeneity of 
repolarization and consequently that of the refractoriness. Second, the reverse use-dependent 
effect of these drugs (i.e. that they cause greater prolongation of the APD at slow versus rapid 
rates of stimulations) is also disadvantageous because at slow heart rate it may cause early 
afterdepolarizations (EAD) and consequently Torsade de Pointes (TdP) type ventricular 
arrhythmias. This phenomenon has been demonstrated with various I& blocking agents, like 
dofetilide, E-4031 etc. and was found to be especially pronounced in Purkinje fibers (20). The 
absence of specific blockers of I^has made it until recently impossible to evaluate directly the 
physiological role of this transmembrane ionic current in cardiac repolarization. Direct 
examination of this current, however, should be of great significance since according to data 
stemmed from guinea pig myocytes, the specific block of IKS might increase APD and 
refractoriness in a frequency-independent manner, preventing thus the proarrhythmic reverse 
use-dependent effect of antiarrhythmic drugs that lengthen repolarization (21). On this basis, 
significant effort has been focused on the development of selective IRS blockers as potential 
antiarrhythmic agents with a more desirable profile of rate-dependent action and safety than 
currently available class III compounds. Chromanol 293B (22) and L-735,821 (23) have 
recently been reported to selectively block IRS in guinea pig cardiac myocytes, but their effects 
on cardiac action potential configuration have not been examined in detail. Possessing these IRS 
blocker compounds, the third important objective of the present study was to establish the role 
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of the two components of Ik in producing normal cardiac action potential repolarization, 
furthermore to compare the effect of the selective inhibition of these two components in dog 
ventricular muscle and Purkinje fiber preparations. Thus, we compared the effects of the 
mentioned Iks blockers to those produced by two recognized, selective I& blockers (E-4031 
and d-sotalol) in the two type of cardiac tissues. 
2. Methods 
2.1. Animals 
Mongrel dogs of either sex (body weights 8-20 kg) were used for the study. The 
animals were untreated, except for the dogs used to study the chronic effect of amiodarone 
which were given 25 mg/kg/day amiodarone (Cordarone, Sanofi) per os for 4 weeks. The 
investigations were in conformity with the Guide for the care and use of laboratory animals 
published by the US National Institutes of Health (NIH publication No 85-23, revised 1985). 
2.2. Preparations 
Endocardial preparations (obtained from papillary muscles and ventricular trabecular 
muscles), as well as epicardial and midmyocardial tissues were isolated from the left ventricle 
of hearts removed from anaesthetized (sodium pentobarbital 30 mg/kg iv.) mongrel dogs of 
either sex. The preparations used for studying M cells were obtained by razor blade shavings 
made parallel to the surface of the ventricular free wall according to the method described by 
Sicouri & Antzelevitch (16). Briefly, the left ventricle was cut from the base to the apex with 
scissors,and small cubes of transmural slices (= 1.5 x 1.0 x 1-1.6 cm) were made at different 
locations of the anterobasal and anteroapical surfaces also with scissors applied to one edge of 
the incision. The slices of ventricular fee wall were then carefully cut by razor blade shavings, 
to obtain final preparations which were 10 to 15 mm long, 10 mm wide and 1 mm thick. M 
cells were recorded from slices located 2-5.2 mm from the epicardial surface. Because we 
found no major differences between the characteristics of papillary muscles and trabeculae, we 
grouped them together as endocardium in the presentation of the results. Free running false 
tendons of Purkinje fibers were excised from the left ventricle of the same hearts. The 
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preparations were placed in a tissue bath and allowed to equilibrate for at least 2 hours while 
superfused with oxygenated (95 % 0 2 : 5 % C02) Tyrode's solution (flow = 4-5 ml/min) 
warmed to 37°C (pH 7.3 ± 0.5) and containing (in mM/1) NaCl 123, KC1 4.7, NaHC03 20, 
CaCl2 1.8, MgCl2 0.8 and D-glucose 10. Preparations were oxygenated also in the tissue bath 
directly. 
2.3. Action potential recordings 
The experiments were carried out by applying standard intracellular microelectrode 
technique, except for the ones examing the effect of almokalant, cibenzoline and chronic 
amiodarone treatment, in which extracellular electrophysiological recordings were used. 
Standard intracellular microelectrode technique: During the equilibration period the tissues 
were stimulated at a basic cycle length (BCL) of 1000 ms. Electrical pulses of 2 ms in duration 
and twice diastolic threshold in intensity (Si) were delivered through Teflon-coated bipolar 
silver electrodes to the preparations. Transmembrane potentials were recorded from one or 
more sites with the use of glass capillary microelectrodes filled with 3 M KC1 (tip diameter < 1 
pM, resistance 10 to 25 Mfi). The microelectrodes were coupled through an Ag-AgCl 
junction to the input of a high-impedance, capacitance-neutralizing amplifier (Biologic VF 
102). The first time derivative of the upstroke of the action potential (AP) was obtained using 
an electronic differentiator (Biologic DV-140), the output of which was linear between 100 
and 1,000 V/s. Intracellular recordings were displayed on a storage oscilloscope (Tektronix 
2232) and led to a computer system (HSE APES) designed for on-line determination of the 
following parameters: resting membrane potential (RP), conduction time (CT), action potential 
amplitude (APA), action potential duration at 50 % and 90 % repolarization (APDso, APD90) 
and the maximal rate of rise of the action potential upstroke (Vmax). In the case of papillary 
muscles, recordings were always made from the apical region, known to be devoid of Purkinje 
fibers. Experiments were not started until the preparations were fully recovered and displayed 
stable electrophysiological characteristics. We applied the following types of stimulation in the 
course of the experiments: stimulation with a constant cycle length of 1000 ms; stimulation 
with different constant cycle lengths ranging from 300 to 10,000 ms (or to 5,000 ms in the case 
of Purkinje fibers in order to avoid spontaneous diastolic depolarization at cycle length of 
10,000 ms). To determine the restitution of action potential characteristics, extra test action 
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potentials were elicited using single test pulses (S2) in a preparation driven at a BCL of 1000 or 
500 ms, depending on the experiment. The Si - S2 coupling interval was increased 
progressively from the end of the refractory period. The effective refractory period was defined 
as the longest Si - S2 interval at which S2 failed to elicit a propagated response. The diastolic 
intervals preceding the test action potential were measured from the point corresponding to 90 
% of repolarization of the preceding basic beat to the upstroke of the test AP and were 
increased progressively. To study the onset kinetics of Vmax, preparations were continously 
stimulated at BCL of 1000 ms. The stimulation was interrupted for 1 minute and then a train of 
40 beats stimuli was applied with BCL of400 ms. 
Extracellular electrophysiological recordings: We used only papillary muscle for this type of 
experiments. The impulse conduction time and the effective refractory period (ERP) were 
measured. To measure conduction time, bipolar extracellular platinum electrodes (diameter = 
0.1 mm) were placed on the surface of the right ventricular wall along the direction of the 
trabecular muscle fibers, 10-12 mm away from the stimulating electrodes, and the propagated 
biphasic action potentials were recorded extracellularly. The propageted extracellular action 
potentials appeared at the recording electrode, and the time difference between the sign of the 
stimulus artifact and the extracellular potential was determined as conduction time. The 
extracellular action potentials were amplified with an amplifier (Eltron GMK) and were 
displayed on the screen of an oscilloscope (Medicor VM62A). The ERP was determined at 
three times the threshold strength using twin impulses with gradually increasing the coupling 
intervals. The stimulation frequency was varied between 3.5 and 0.5 Hz. 
2.4. Drugs 
Drugs were diluted in normal Tyrode's solution to obtain the following final 
concentrations: 10 |iM/I cibenzolin (UPSA), 100 nM/1 almokalant (ASTRA, Sweden), 25 
mg/kg/day for 4 weeks (chronic treatment) + 5 uM/1 amiodarone (Sanofi, France) into the 
tissue bath, 10 pM/1 desethylamiodarone (Sanofi, France), 10 uM/1 dronedarone (SR-33589) 
(Sanofi, France), 10 uM/1 ambasilide (Knoll AG, Germany), 30 uM/1 d-sotalol (Bristol-Myers 
Squibb, UK), 10 pM/1 chromanol 293B (Hoechst AG, Germany) 100 nM/1 L-735,821 (MSD, 
USA), 1 pM/I E-4031 (GYKI, Budapest), 10 pMZI pinacidil (GYKI, Budapest), 2 .uM/1 
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tetrodotoxin (Sigma, St. Louis, USA), 2 jxM/1 nifedipine (Sigma, St. Louis, USA). All 
measurements were begun 15-30 min after the APD and Vmas reached stable values. 
2.5. Statistics 
All data are expressed as mean ± SEM. Statistical analysis was performed using 
Student's t test for paired or unpaired data, as indicated and the nonparametric form of analysis 
of variance coupled with the Mann-Whitney and Bonferroni procedures. The results were 
considered to be significant at P < 0.05 level. 
3. Results 
3.1. Electrophysiological effects of cibenzoline, almokalant and chronic amiodarone 
treatment on canine right ventricular trabecular muscle 
Since the publication of the CAST study (6), significant interest has been focused on 
antiarrhythmic drugs which delay repolarization in cardiac muscle. Antiarrhythmic drugs that 
inhibit Ik (Class III drugs) act to suppress arrhythmias primarily by lengthening the reffacter 
period of atrial and ventricular myocardium and as a consequence they are effective in the 
termination as well as prevention of both supraventricular and ventricular reentrant 
tachycardia. In accordance with the above, we studied and compared the cellular 
electrophysiological effects of three antiarrhythmic drugs (cibenzoline, almokalant and 
amiodarone) which delay repolarization, in isolated dog right ventricular trabecular muscle by 
applying extracellular electrophysiological technique (24). The effects of 100 nM/1 almokalant, 
10 pM/1 cibenzoline and chronic amiodarone treatment (p.o. 25 mg/kg/day for 4 weeks + 5 
pM/1 amiodarone in the tissue bath) were measured on the ERP and impulse conduction time 
at a wide range of stimulation frequencies (0.5-3.5 Hz). The possible effects of the drugs on 
the ATP-sensitive potassium current (IK-ATP) were tested by activating the IK-ATP channels with 
2 pM/1 cromakalim, the effect of which results in the opening of these channels and as a 
consequence in the shortening of the ERP. We found that all three drugs significantly 
lengthened ERP at 1 Hz stimulation frequency. The impulse conduction time was not changed 
by almokalant at any of the stimulation frequencies. In contrast, cibenzoline significantly 
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increased conduction time (29.8 ± 7.3%; n = 8; p < 0.05) at low stimulation frequency (05 
Hz), which effect was enhanced by faster rate of stimulation (3.5 Hz = 49.4 ± 9.3%; n = 8; p < 
0.05) (Fig. 1/A). Chronic amiodarone treatment depressed impulse conduction only at 
stimulation frequencies higher than 1 Hz which effect was intensified by faster stimulation (1 
Hz = 7.5 ± 1.5%; n = 22; p < 0.05; 3.5 Hz = 32.9 ± 1.6%; n = 22; p < 0.05) (Fig. 1/B). These 
results suggest the use-dependent inhibition of the fast sodium channels, although there is an 
important difference between the mode of inhibition of the two drugs: in contrast to 
amiodarone, cibenzoline depressed impulse conduction also at normal and slow heart rate, 
which effect seems to be undesirable from therapeutic point of view as it can increase 
proarrhythmic risk. 
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Figure 1. Frequency-dependent effect of cibenzoline (10 pM/1) (Panel A), and chronic 
amiodarone treatment (25 mg/kg/day, 4 weeks + 5 pM/1 amiodarone in the tissue bath) (Panel 
B) on the impulse conduction time in dog ventricular muscle. Mean ± SEM values are shown. 
Asterisks denote P < 0.05 versus control. 
Studying the possible effects of the drugs on the TK-ATP, it was found that cibenzoline markedly 
reduced the ERP shortening effect of cromakalim (control = -19.7 ± 3.5%; cibenzoline = -5.4 
± 1.3%; n = 10; p < 0.05) suggesting the inhibition of the ATP-sensitive potassium channels 
that play an important role during cardiac ischaemia (Fig. 2). No such effect was observed with 
almokalant and amiodarone. 
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Figure 2. Effects of almokalant (100 nM/1), cibenzoline (10 pM/1) and amiodarone (25 
mg/kg/day, 4 weeks + 5 pM/1 amiodarone in the tissue bath) on the cromakalim-induced 
effective refractory period (ERP) shortening. The ERP change represents the percent 
difference between ERP values in the absence and presence of the drugs. Mean ± SEM values 
are shown. Asterisks denote P < 0.05 versus control. 
3.2. Comparison of the cellular electrophysiological effects of desethylamiodarone, 
dronedarone and amiodarone in canine ventricular muscle and Purkinje fibers 
Amiodarone is regarded nowadays as the most effective drug available for cardiac 
rhythm disturbances, exhibiting a uniquely complex spectrum of electropharmacological action, 
the properties of which belong to all four antiarrhythmic classes (13). It has been proven by 
large clinical trials that it has an extremely potent antiarrhythmic activity, and in addition to its 
ability to suppress effectively both ventricular and supraventricular arrhythmias, some studies 
showed that it was also able to reduce significantly mortality due to sudden cardiac death (13). 
It is well-known that the effects of acute and chronic administration of amiodarone are 
considerably different (13,25,26). On the basis of earlier experiments it can be expected that 
the cardiac electrophysiological effects of chronic amiodarone treatment are, at least partly, 
due to the formation and accumulation of an active metabolite, N-desethylamiodarone in the 
plasma and tissues (27). Since the electropharmacological characteristics of this important 
active metabolite have not been entirely elucidated, I have examined the acute in vitro effects 
of 10 pM/1 desethylamiodarone over a wide range of stimulation cycle lengths in canine cardiac 
Purkinje and ventricular muscle fibers, and compared them with those of amiodarone (28). It is 
known that APD in the Purkinje fibers is normally longer than that in the ventricular muscles. I 
found that in Purkinje fibers at stimulation cycle length of 1000 ms (1 Hz), desethylamiodarone 
produced significant shortening in APD at both 50% and 90% repolarization (from APD50 = 
318.0 ± 21.6 ms to APDS0 = 231.7 ± 19.4 ms; n = 5; p < 0.05 and from APD«, = 413.2 ± 30.5 
ms to APD«, = 362.0 ± 28.1 ms; n = 5; p < 0.05) and it also shortened APD«, at different 
constant cycle lengths and at abrupt changes in stimulation cycle length (restitution) as well. In 
ventricular muscle, however, desethylamiodarone did not prove to change APD neither at 
stimulation cycle length of 1000 ms, nor at different constant cycle lengths. The observed acute 
effect of the metabolite on APD ressembles that of amiodarone which due to its acute and 
especially chronic effect on repolarization is regarded to be at present the only antiarrhythmic 
drug, that act to reduce transmural dispersion of repolarization (TDR) at all stimulation 
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frequencies and therefore contributing to an overall electrical stability in the heart (25,26). 
Studying the effect of desethylamiodarone on the maximal rate of rise of depolarization, we 
observed a marked use-dependent depression of V M A X in Purkinje fibers (at BCL of400 ms = -
28.4 ± 6.6%; n = 5; p < 0.05) with a recovery time constant of x = 341.85 ± 81.6 ms (n = 5), 
that appears to be similar to that of amiodarone. Examing the same parameter in ventricular 
muscle, desethylamiodarone exerted moderate use-dependent depression of Vmax (at BCL of 
400 ms = -14.3 ± 9.4%; n = 5). The use-dependent effect on V M A X (i.e. the largest depressant 
effect occurred at the shortest stimulation cycle length applied) suggests the depression of 
inactivated fast sodium channels, and this is consistent with a Class IB antiarrhythmic effect, 
i.e. with a relatively fast recovery time constant from sodium channel block (29). These results 
demonstrate that desethylamiodarone possesses significant acute electrophysiological effects, 
which proved to be different in cardiac Purkinje and ventricular muscle fibers and similar to 
those observed earlier with the parent compound amiodarone. 
Despite its efficacy, however, amiodarone causes various extracardiac side effects 
which limit its usefulness. Thus great effort has been made in order to develop new compounds 
with similar electrophysiological profile, but lacking side effects. Dronedarone (SR-33589), a 
novel derivative structually related to amiodarone, but without iodine substituents, is such a 
compound; it has been found to be effective in various in vivo experimental arrhythmia models 
(30). Our aim was to characterize the acute in vitro cellular electrophysiological effects of 
dronedarone and to compare them with those of amiodarone (31). The experiments were 
carried out in canine papillary muscles and Purkinje fibers. Dronedarone (10 pM/1), like 
amiodarone (10 pM/1), did not significantly change or only slightly lengthened APD at BCL of 
1000 ms in papillary muscle, but shortened the same parameter significantly in Purkinje fibers 
(dronedarone: 308.6 ± 12.4 to 283.8 ± 12.4 ms; n = 6; p < 0.01 and amiodarone: 307.0 ± 16.5 
to 279.7 ± 11.9 ms; n = 7; p < 0.01). Both dronedarone and amiodarone exerted use-
dependent IB type Vmax block and suppressed EADs induced by dofetilide + BaC12 in Purkinje 
fibers. It was concluded that despite its lack of iodinated substituents, dronedarone exerts 
similar acut electrophysiological effects to those of amiodarone, and this finding could account 
for its promising role in the treatment of ventricular arrhythmias. 
3.3. Electrophysiological effects of ambasilide, a new antiarrhythmic agent, in canine 
isolated ventricular muscle and Purkinje fibers 
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Ambasilide (LU 47710) is a novel Class III agent, the chemical structure of which 
differs from that of sotalol and other methanesulfonyl benzamides recently synthesized and 
being investigated for Class III electrophysiological properties. On the basis of data from the 
literature, multiple pharmacological actions of ambasilide can be presumed (32,33,34). The aim 
of the study was to determine the in vitro rate-dependent cellular electrophysiological effects 
of ambasilide (10 and 20 pM/1), in canine isolated ventricular muscle and Purkinje fibers 
applying standard microelectrode technique. 
The effects of 10 and 20 pM/1 ambasilide on the action potential parameters of canine 
ventricular muscle and Purkinje fibers at a BCL of 1000 ms are summarized in Table 1. 
Table 1. Effects of ambasilide on canine action 
potential parameters at cycle length of 1000 ms 
Ambasilide (10 pM/1) lengthened 
APD50 and APD90 significantly in 
papillary muscles without causing 
considerable change in the action 
potential parameters. In Purkinje 
fibers the same concentration 
increased only APD90 significantly. 
The effects of 20 pM/l ambasilide 
were similar to those of 10 pM/1 in 
ventricular muscle. In the case of 
Purkinje fibers, however, there 
were important differences between 
the effects of the two 
concentrations on APD50 and 
APD90. A lengthening of APD90 
was observed in the presence of both concentrations of the drug, but while 10 pM/1 ambasilide 
produced a marked prolongation (25.5% ± 1.9; p < 0.01; n = 6), 20 pM/1 exerted a smaller 
effect (11.3% ± 3.0; p < 0.05; n = 6). As concerns the effects on APD50 in Purkinje fibers, 10 
pM/1 ambasilide caused prolongation, while 20 pM/1 exerted a significant abbreviation. These 
effects of 10 and 20 pM/1 ambasilide exerted on dog ventricular muscle and Purkinje fiber 
action potential configurations are shown in Figure 3/A and B. 
10 pM/1 20 pM/1 
Ventricular ambasilide ambasilide 
muscle (n =8) (n =8) 
Control Drug Control Drug 
RP -88±0.6 -90±1.1 -85±0.9 -85±0.6 
APA 111±1.6 112±1.6 106±1.1 105±1.1 
APD50 219±10.4 254±13.3* 204±5.6 228±5.9* 
APD90 261±8.1 323±12.9f 242±5.7 289±6.6f 
V v max 219±29.2 208±31.4 230±9.5 219±9.2 
10 pM/1 20 pM/1 
Purkinje ambasilide ambasilide 
fiber (n=8) (n= =8) 
Control Drug Control Drug 
RP -89±1.0 -89±1.9 -87±0.6 -85±0.8 
APA 112±3.5 112±2.0 117±1.2 113±2.1 
APD5O 193±16.5 208±20.4 236±10.6 145±4.6f 
APD90 275±16.6 369±19.5f 321±9.9 361±7.2* 
v 
* max 
416±14.0 419±22.3 445±14.6 413±15.8 
* p < 0.05; f P < 0 001 
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The rate-dependent effect of ambasilide on APD90 was also studied. 10 pM/1 Ambasilide was 
found to produce a similar degree of increase in APD90 at CLs 400 (16.1 ± 3.2%; p < 0.05; n = 
8) and 3000 ms (21.9 ± 2.9%; p < 0.05; n = 8) in papillary muscles (Fig. 4/C). 
VENTRICULAR MUSCLE 
O C o n t r o l 
B 
PURKINJE FIBRE 
Figure 3. Action potential 
recordings from canine ventricular 
papillary muscles (Panel A) and 
Purkinje fiber strands (Panel B) 
before (control) and after 
superfusion for 40 minutes with 
10 (top) and 20 pM/1 ambasilide 
(bottom). 
In contrast, the same 
1 1 concentration of ambasilide 
exerted a more pronounced increase in APD90 in Purkinje fiber preparations at long CLs; the 
difference tended to disappear at higher stimulation frequencies (CL = 400 ms) (Fig. 4/A). 
Examining the same effect of ambasilide in the concentration of 20 pM/1 in ventricular muscle, 
we observed an even more homogenous prolongation of APD90 at all frequencies studied than 
with 10 pM/1 (at CL = 400 ms: 16.9 ± 1.4%; p < 0.05; n = 9 and at CL = 3000 ms: 18.2 ± 
1.5%; p < 0.05, n = 9) (Fig. 4/D). In Purkinje fibers, however, the higher concentration of the 
drug caused less change in APD90 than that observed with 10 pM/1. (Fig. 4/B). 
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Figure 4. Rate-dependent effect of 
10 and 20 pM/1 ambasilide on 
APD90 in dog Purkinje fibers (Panel 
A and B) and in right ventricular 
papillary muscles (Panel C and D). 
Mean ± SEM values are shown. 
Asterisk denotes P < 0.05 versus 
control. 
We also studied the effect of 
ambasilide on the rate-dependent 
depression of Vmax. In papillary 
muscle preparations the Vmax 
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1000 2000 3000 4000 5000 depression caused by the drug (20 
CL(ms) 
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gM/1) was strongly cycle length dependent, i.e. significant effect was observed only within the 
CL range of 300-1000 ms (Fig. 5/A). The drug affected also the conduction time (CT) in 
papillary muscle. Similarly to the inhibitory effect on Vmax, also this effect proved to be 
significant only within the CL range of 300-700 ms and the difference tended to disappear at 
CLs longer than 1000 ms (Fig. 5/B). 
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A r Figure 5. Rate-dependent inhibition of Vmax caused by 20 pM/1 ambasilide in canine ventricular muscle. The inhibition of Vmax represents the percent difference between Vmax values 
in the absence and presence of the 
drug. (Panel A) Rate-dependent effect 
of 20 pM/1 ambasilide on conduction 
time (CT) in canine right ventricular papillary muscles. (Panel B) Mean ± SEM values are 
shown. Asterisk denotes P < 0.05 versus control. 
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ambasilide on the recovery of 
Vmax (Panel A) and on the onset 
kinetics of Vmax (Panel B) in 
canine right ventricular papillary 
muscles. Basic cycle length was 
500 ms. In Panel A the ordinate 
indicates Vmax values of the 
extrasystoles, elicited at 
progressively increasing diastolic 
intervals. The abscissa shows the 
diastolic intervals in seconds. 
Values are shown as mean. For 
the sake of clarity SEM is not 
indicated. (Range: 11.4 to 19.4 
V/s.) In Panel B following a 1 min. stimulation free period, the Vmax values of a train of 40 
beats at a BCL of 400 ms are presented. The ordinate indicates the Vmax values, the abscissa 
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As the determinants of Vmax are known to differ between steady-state and non-steady-state 
stimulation conditions, we also examined the characteristics of restitution of this parameter in 
ventricular muscle preparations. Figure 6/A shows the recovery of Vmax in 6 papillary muscle 
cells in the abscence and presence of 20 pM/l ambasilide. The restitution curves show that the 
drug slowed the recovery of V m a x with a recovery time constant of x = 1082.5 ± 205.1 ms (n = 
6), which appears to be close to that reported with Class I/B agents. The onset kinetics of Vmax 
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block induced by 20 pM/1 ambasilide was also studied in dog right ventricular papillary muscle. 
(Fig. 6/B). Preparations were continously stimulated at BCL of 1000 ms. The stimulation was 
interrupted for 1 minute and then a train of 40 beats stimuli was applied with BCL of 400 ms 
(Fig. 6/B). In control conditions there was only a minor change (17.3 V/s) between the first 
and last Vmax values in the train. In the presence of 20 pM/1 ambasilide, however, a large (80.9 
V/s) use-dependent Vmax block developed with a rate constant of 8.9 ±2.1 (n = 9). The onset 
kinetics of Vmax block induced by ambasilide in this study was found to be intermediate 
between Class I/B and 1/C antiarrhythmic drugs and was similar to that reported of 
disopyramide and quinidine (35). 
3.4. Comparison of the cellular electrophysiological characteristics and responsiveness to 
tetrodotoxin, nifedipine and pinacidil of canine left ventricular epicardium, M cells, 
endocardium and Purkinje fibers 
One of the important goals of this study was to provide further in vitro characterization 
of the existing differences among the four tissue types of the dog ventricle over a wide range 
of stimulation cycle lengths, examing the electrophysiological and pharmacological 
heterogeneity caused by them, and the relevance of this heterogeneity in physiological and 
pathophysiological function. Since the majority of studies thus far available on this topic 
suggest that M cells bear outstanding resemblance with Purkinje fibers and share only minor 
similarities with epicardial and endocardial cells, I have focused my investigations especially on 
the electrophysiological and pharmacological differences between M and Purkinje cells of the 
canine ventricle (36). The experiments were carried out by applying standard intracellular 
microelectrode technique in isolated dog left ventricular preparations. 
Action potentials recorded from preparations isolated from the epicardial, midmyocardial, 
endocardial regions and from Purkinje fibers of the canine left ventricle are illustrated in Figure 
7. The four traces were recorded from the respective regions of the ventricle during stimulation 
of the preparations at a BCL of 300, 1000 and 5000 ms. Action potentials recorded from 
epicardial and M cells as well as from Purkinje fibers display a distinct early repolarization 
phase (phase 1) that is less obvious in endocardial cells. M cells differ from epicardial and 
endocardial cells but resemble Purkinje fibers with respect to phase 3 repolarization, showing a 
greater prolongation of the action potential with slowing of the stimulation rate. It is worth 
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mentioning that the plateau phase of the action potentials in Purkinje fibers developed at less 
positive potential (-5.4 ± 1.6 mV), than that in M cells (9.8 ± 1.3 mV), endocardial (13.3 ± 1.8 
mV) or epicardial fibers (17.1 ± 1.1 mV). 
Figure 7. Transmembrane action potentials 
(right panel) recorded under steady-state 
conditions at BCLs of 300 (star), 1000 (square) 
and 5000 ms (diamond) from epicardium, M 
cells, endocardium and Purkinje fibers isolated 
from the canine left ventricle. The maximal rate 
of rise of the action potential upstroke (Vmax) 
(left panel) recorded from the respective 
regions of the left ventricle at a BCL of 1000 
ms (square). 
Table 2 summarizes the action potential 
parameters of the four tissue types at the BCL 
of 1000 ms that approximates to normal human 
heart rate (60 beats/min). It was found that M 
cells and Purkinje fibers displayed a resting 
membrane potential more negative than that in epicardial and endocardial cells. Action 
potantial amplitude in Purkinje fibers was considerably higher than that observed in the 
different types of ventricular muscle fibers. The APD recorded in M cells at the BCL of 1000 
ms was longer than that recorded from epicardial or endocardial cells although only the 
difference between M cells and epicardial cells proved to be significant, and was considerably 
shorter than the APD measured in Purkinje fibers. M cells displayed a Vmax significantly greater 
than that of either epicardial or endocardial cells, but the Vmax in M cells was less in magnitude 
than that in Purkinje fibers. Interestingly, the distribution of Vmax values recorded in M cells 
demonstrated a marked variance in magnitude. Since endocardial and epicardial cells in normal 
conditions have a V m a x value smaller than 300 V/s, we arbitrarily divided the Vmax values of 37 
individuel M cells into two subgroups, under and above 300 V/s. In 14 of 37 preparations it 
was found that the Vmax value was greater than 300 V/s with a mean of 397.7 ±18.5 V/s, 
while in 23 preparations Vmax was measured less than 300 V/s with a mean of 214.8 ± 10.2. 
The distribution of Vmax values in magnitude exhibited by M cells raised the question as to 
whether the other action potential parameters of the midmyocardial region can also be divided 
into two subgroups. It can be expected that parameters like Vmax, which correlates with the 
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intensity of the sodium current during the action potential upstroke, may be considerably 
greater in M cells possessing a Vmax higher than 300 V/s, but smaller in cells with a less 
pronounced maximal rate of rise of the action potential upstroke. In accordance with this 
expectation, we found that the action potential amplitude beared similarity with the variance of 
Vmax These features of action potential parameters in M cells are demonstrated in Table 3. 
Table 2. 
Action potential parameters of endocardial, M, epicardial cells and Purkinje fibers 
recorded from canine left ventricular preparations at basic cycle length of 1,000 ms 
E N D O C A R D I U M M CELL EPICARDIUM PURKINJE FIBER 
(n = 28) (n = 37) (n = 29) (n = 20) 
R P -84.3 ± 0.9 -86.5 ± 0.8 -84.2 ± 0.7 -89.6 ± 0.9 * f * 
(mV) 
A P A 108.7 ± 1.5f 108.4 ± 1.5f 101.3 ± 1.2 124.6 ± 1.7 * f * 
( m V ) 
A P D 90 238 .6 ± 5 . 0 258.7 ± 4 .5f 222.1 ± 5.3 324.8 ± 1 5 . 4 * f * 
( m s ) 
v max 176.9 ± 7.0* 284.0 ± 17.5f 154.5 ± 6.6 505.0 ± 3 2 . 7 * f | 
( V s"1) 
Values are mean ± SEM; Significance was determined by the nonparametric form of analysis of 
variance coupled with the Mann-Whitney and Bonferroni procedures. * p < 0.01 vs M cell; f p 
< 0.01 vs epicardium; % p < 0,01 vs endocardium 
V„ > 300 V/s 
(n=14) 
V, 
BCL of 10,000 ms vs 1000 ms 
APD9q prolongation (%) 36.0 ±6.4 
max < 300 V/s 
("=23) 
BCL of 1000 ms 
Vmax (V/S) 397.7 ± 18.5* 214.8 ± 10.2 
RP (mV) -89.1 ± 1.2f -85.0 ± 1.0 
APA (mV) 114.2 ± 1.8* 104.8 ± 1.7 
APD90 (mV) 260.8± 8.2 257.4 ±5.2 
47.7 ±5.5 
Table 3. Distribution of 
APD parameters in M 
cells from canine left 
ventricle preparations at 
cycle length of 1000 
and 10,000 ms (* p < 
0.001; t p < 0 . 0 5 ) 
The main characteristic of M cells which differentiates them from the other ventricular cell 
types and makes them more similar to Purkinje fibers, is the more accentuated rate dependence 
of their action potential duration. To study this property, we stimulated the preparations at 
BCLs ranging from 300 to 10,000 ms (or to 5000 ms in the case of Purkinje fibers in order to 
avoid spontaneous diastolic depolarization at cycle length of 10,000 ms). At the BCL of 300 
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ms all the four cell types displayed relatively short action potentials of almost similar duration. 
With progressive slowing of the stimulation rate, APD of M cells was prolonged to a much 
greater extent than the APD of epicardial and endocardial cells. In the left ventricle, an 
increase of the BCL from 1000 to 10,000 ms caused a 41% increase in the APD90 of M cells, 
but an increase of only 14% in epicardial and 13% in endocardial fibers. In Purkinje fibers, a 
deceleration of rate from 1000 to 5000 ms produced a dramatic prolongation of APD similar 
to that of M cells (35%). Thus, the APD-rate relations are remarkably more prominent in M 
cells than those in epicardium or endocardium, and similar to those in Purkinje fibers, which 
are known to prolong more excessively relative to the other cell types when stimulation rate is 
slowed. 
The characteristics of restitution of APD was also examined and compared in the four cell 
types. The APD restitution curves illustrated in Figure 8. show remarkable distinction between 
the restitution of APD in M cells and Purkinje fibers representing an important 
electrophysiological difference between the two types of fiber, which has not been described 
yet. The restitution curves in endocardial and epicardial fibers were relatively similar. The two 
exponentials fit on the average curves showed Xfast = 60.9 ms, tsiow = 32.7 s and ifast= 55.8 ms, 
Tsiou = 29.2 s, respectively. The corresponding amplitude values of the fit were Afast = 41.1 ms, 
Asiow = 30.1 ms and Afast = 20.1 ms, Asiow = 35.3 ms, respectively. The APD restitution of M 
cells is somewhat different from that of endocardium and epicardium. In these fibers the fast 
component of restitution had a x ^ of 17.4 ms (Atast = 29.9 ms ) but, as considerable difference 
from epicardial and endocardial fibers, the amplitude of the slow component was relatively big 
(Asiow = 104.1 ms) with similar kinetic parameter (tsiow = 23.8 s). Purkinje fibers, exhibit 
completely different course of APD restitution with high amplitudes (Afas, = 150.6 ms, Asiow = 
77.6 ms) and relatively slow fast time constant of restitution (Xfast = 127.6 ms) and relatively 
fast (xsiow = 3.7 s) slow time constant of restitution. 
Figure 8. Restitution of APD90 in 
epicardium (square), endocardium (star), M 
cells (triangle) and Purkinje fibers (circle) 
isolated from the canine left ventricle. BCL 
was 1000 ms. The ordinate indicates APD90 
values of the extrasystoles, elicited at 
progressively increasing diastolic intervals, 
in ms. The abscissa shows the diastolic 
intervals. In the early portion of restitution 
the time scale was expanded in order to 
illustrate better the initial phase of 
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restitution. Values are shown as mean ± SEM. 
The change in the APD of extrasystoles elicited once after every 10th basic beat at early (20 
ms) and at very late (60 s) diastolic intervals was also determined and compared in all four 
types of tissue. As Figure 9 shows, in case of extrasystoles elicited at early diastolic intervals 
(20 ms), the pattern of APD changes in endocardial, epicardial and M cells was strikingly 
different from that in Purkinje fibers; i.e., the APD of the premature beat shortened only 
moderately in endocardial, epicardial and M cells in comparison with the APD of the basic beat 
(15.6 ± 1.6 %, n = 24, 9.5 ± 1.9 %, n = 23, and 7.6 ± 2.0 %, n = 38, respectively), while the 
same parameter in Purkinje fibers showed a marked reduction (46.3 ± 1.6 %, n = 19). 
M cell 
n=38 
Purkinje fiber 
n= 19 
Extrasystole 
early | | diastolic interval = 20 ms 
late diastolic interval = 60s 
Figure 9. Cycle length 
dependent APD at early (20 
ms) and late (60 s) diastolic 
intervals in endocardium, 
epicardium, M cells and 
Purkinje fibers of the canine 
left ventricle. Changes in the 
APD of extrasystoles elicited 
once after every 10th basic beat 
at early (grey columns) and late 
diastolic intervals (black 
columns) are expressed as a 
percentage of the APD of the 
basic beat. 
This means that the early portion of the APD restitution curve in M cells is more similar 
to that of endocardial and epicardial cells than to Purkinje fibers. Regarding the change in the 
APD of extrasystoles elicited at late diastolic intervals (60 s), we found a great prolongation in 
M cells (40.0 ± 4.6 %, n = 38) and in Purkinje fibers (15.4 ± 1.7 %, n = 19), but only a slight 
increase in endocardial and epicardial cells (16.7 ± 2.6 %, n = 24 and 15.3 ± 3 . 1 %, n = 23, 
respectively). As far as the prolongation of APD of extrasystoles recorded in Purkinje fibers is 
concerned, we have to note that the longest diastolic interval in this type of tissue was 10 s to 
avoid automaticity. Considering the APD restitution curve in Purkinje fibers, it is likely that a 
quantitatively similar lengthening of APD to that of M cells could have been obtained, if the 
largest diastolic interval had been 60 s like in epicardial, endocardial and M cells. 
Considering the electrophysiological heterogeneity among the four types of tissue, it can be 
expected that they respond differently to pharmacological interventions. Therefore we studied 
the pharmacological responses of the four tissue types, investigating the effects of tetrodotoxin 
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(TTX 2 pM/1), nifedipine (2 pM/1) and pinacidil (10 pM/1) on the APD of the preparations at 
BCL of 1000 ms (Fig. 10.). 
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Figure 10. Block diagram 
illustrating the APD shortening 
effects of tetrodotoxin (TTX 2 
pM/1), nifedipine (2 pM/1) and 
pinacidil (10 pM/1) on canine left 
ventricular endocardium (white), 
epicardium (grey), M cells (black) 
and Purkinje fibers (striped 
columns) at aBCL of 1000 ms. 
Changes in APD are expressed as 
percentage of control APD in the 
presence of the drugs. Vertical 
bars indicate SEM. * denotes p < 
0.05 vs control. 
It was found that after 10 minutes of exposure to 2 pM/1 tetrodotoxin, APD was shortened in 
both M cells and Purkinje fibers significantly, whereas no significant changes in APD were 
observed in epicardium or endocardium after application of this agent. Despite the qualitatively 
similar effect of TTX on M cells and Purkinje fibers, it has to be emphasised that the degree of 
APD abbreviation was more accentuated in Purkinje fibers than in M cells (52.8 ± 5.5 %; n = 
6; and 8.2 ± 4.2 %; n = 6; respectively), suggesting a weaker contribution of the sodium 
current to repolarization in M cells than in Purkinje fibers, findings making M cells to be more 
akin to epicardial and endocardial cells. The calcium channel blocker nifedipine produced a 
significant reduction in APD of all the four cell types, and the shortening effect caused by this 
drug did not show considerable difference among any of the preparations. The ATP-sensitive 
potassium channel opener pinacidil significantly shortened repolarization in all types of tissue, 
although APD in Purkinje fibers was abbreviated to a larger extent than APD in endocardial, 
epicardial and M cells. Thus we can conclude that, similarly to our results concerning the 
inhibition of the slowly inactivating sodium current, the effect of IK-ATP activation with 
pinacidil was similar in epicardial, M and endocardial tissues, but much greater in Purkinje 
fibers. 
3.5. Comparison of the electrophysiological effects of specific blockers of Iks andlKr in 
dog ventricular muscle and Purkinje fiber repolarization 
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Direct and detailed investigation of Irs - the slowly activating component of Ik - should 
be highly important since 1. the relative small density of this current was supposed to be 
responsible for the longer APD in M cells (19), 2. previous data obtained in the guinea pig 
suggested that compounds with selective Irs blocking properties have a more desirable profile 
of rate-dependent action and thereby better safety than currently available Class III compounds 
(18). Recently two compounds, chromanol 293B and L-735,821 were reported to block Irs 
with great specifity in guinea pig cardiac myocytes (22,23), but their actions on the cardiac 
action potential have not been studied in detail. Therefore we examined the cellular 
electrophysiological effects of these agents (10 pM/1 and 100 nM/1, respectively), investigating 
the possible role of Irs in repolarization. A comparison with the role of Ir, was also made using 
the specific Irt blockers d-sotalol (30 pM/1) and E-4031 (1 pM/1). The experiments were 
carried out by applying standard intracellular microelectrode technique and the whole-cell 
configuration of the patch-clamp technique in dog ventricular muscle and Purkinje fibers at 37 
°C (37). 
My colleague, Norbert lost examined the effects of E-4031 and d-sotalol on Irt, as well as the 
effects of chromanol 293B and L-735,821 on Irs in isolated dog ventricular myocytes. It was 
found that E-4031 (1 pM/1) completely abolished and d-sotalol (30 pM/1) attenuated Irt tail 
currents. Similarly, chromanol 293B (10 pM/1) greatly reduced and L-735,821 (100 nM/1) 
completely abolished Irs (37). The next step was to study the effects exerted by equipotent 
concentrations of chromanol 293B and L-735,821 that blocked Irs on dog ventricular muscle 
and Purkinje fiber action potential configuration (Fig. 11) and to compare them with those of 
d-sotalol and E-4031 that blocked Irt (Fig. 12) at a BCL of both 1000 ms and over a wide 
range of stimulation cycle lengths (300 - 5000 ms) as well (Fig. 13). 
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• 100 nM L-735,821 Figure 11. Action potential recordings 
from dog right ventricular papillary 
muscles (Panel A) and Purkinje fiber 
strands (Panel B) before and after 40 
minutes superfusion with 100 nM/1 L-
735,821 (top) or 10 pM/1 chromanol 
293B (bottom) at BCL of 1000 ms. 
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Figure 12. Action potential 
recordings from dog right 
ventricular papillary muscles 
(Panel A) and Purkinje fiber 
strands (Panel B) before and after 
40 minutes superfusion with 1 
pM/1 E-4031 (top) or 30 pM/1 d-
sotalol 293B (bottom) at BCL of 
1000 ms. 
Chromanol 293B and L-735,821 produced small changes in APD amounting to less than a 7% 
increase over baseline measurements, and these unremarkable effects of Ik* demonstrated little 
frequency dependence in both ventricular muscle and Purkinje fiber strands (Fig. 13.). In 
contrast, d-sotalol and E-4031 markedly lengthened both dog papillary muscle and Purkinje 
fiber APD (Fig. 12.) In addition, the increase in APD following Ikt block occurred in a reverse 
frequency-dependent fashion so that the increase in APD was always greater at long cycle 
lengths than at short ones (Fig. 13.). 
Figure. 13. Rate 
dependent effect of 
Ikt (by E-4031 or d-
sotalol), and Iks 
block (by chromanol 
293B or L-735821) 
on APD in dog 
ventricular muscles 
(Panel A) and 
Purkinje fibers 
(Panel B) Values 
are shown as mean ± 
SEM. 
These results clearly show that Ikt block lengthens APD greatly, while selective Ik« block in 
dog has little effect on normal cardiac APD in both ventricular muscle and Purkinje fibers. 
Since Iks is modulated by changes in intracellular cAMP, we also examined the effects of Irs 
block on APD in the presence of 1 pM/1 forskolin to activate adenylcyclase and increase 
intracellular cAMP (Fig. 14). Forskolin alone (n = 18) markedly shortened APD in dog right 
VENTRICULAR MUSCLE B PURKINJE FIBER 
O CONTROL 
• 1 MM E-4031 
O CONTROL 
• 30 pM SOTALOL . 
40 
36 
30 
g . 
Ol 2 0 
O 
Û. 
< 10 
I -
0.3 
VENTRICULAR MUSCLE 
1 (JM E-4031 
• 30 )JM SOTALOL 
A 10 JJM CHROMANOL 293B 
• 100 nM L-735,821 
1 2 3 
C y c l e l e n g t h ( s ) 
120 
110 
100 
90 
80 
£ 70 
Ol 60 c 
60 -C o 
o 40 
Q_ 30 < 
20 
10 
0 
B 
PURKINJE FIBER 
** 1 M M E-4031 
• 30 (JM SOTALOL 
A. 10 )lM CHROMANOL 293B 
• 100 nM L-735,821 
. n ^ 
i t n^  
I — I — I — r 
0 0.4 
- I — I — I — I — I 
0.8 1.2 1.6 
C y c l e l e n g t h ( s ) 
26 
ventricular papillary muscle at BCLs ranging between 300 and 5000 ms (i.e. from 190.2 ± 4.4 
ms to 157.1 ± 3.3 ms and 258.2 ± 5.7 ms to 212.5 ± 4.2 ms, respectively, at BCLs of 300 and 
5000 ms). Addition of L-735,821 (100 nM/1) or chromanol 293B (10 pM/1) in the continuous 
presence of forskolin had little effect on APD (150.2 ± 2.2 ms versus 153.2 ± 2.6 ms and 207.5 
± 3.4 ms versus 209.0 ± 4.5 ms following L-735,821 and 164.1 ± 4.3 ms versus 176.0 ± 4.2 
ms and 217.6 ± 5.1 ms versus 234.9 ±9 .1 ms following chromanol 293B at BCLs of 300 and 
5000 ms, respectively). These results show again that selective Iks block only slightly 
lengthened APD over a wide range of stimulation frequencies, even in the presence of elevated 
intracellular cAMP. 
Based on the data of the experiments carried out by our team (37) that measured the 
amplitudes and activation and deactivation time constants of Ikt and Iks tail currents, the 
magnitude of IRS and IR, activated during the cardiac action potential were assessed, trying to 
to demonstrate the ratio of contribution of these two currents to the repolarization phase of the 
action potential in the dog ventricle (37). In agreement with earlier results (38), also in our 
study Ikt activated rapidly during action potentials but deactivated slowly, while activated 
slowly at more positive potentials. In addition, Irs accumulation over successive depolarisation 
is not likely since its deactivation is fast with respect to diastolic intervals occurring at 
physiological heart rates. 
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Figure 14. Frequency 
dependent effect of the Irs 
block by 100 nM/1 L-
735,821 (Panel A) or 10 
pM/1 chromanol 293 B 
(Panel B) in the presence of 
1 pM/1 forskolin on APD in 
canine ventricular papillary 
muscles. Values are shown 
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Ikt and Irs kinetics such as these may account for the small effect of chromanol 293B and L-
735,821 on APD at concentrations that completely or markedly blocked IRs in the present 
study. Furthermore, currents measured during and after 200 ms rectangular and artificial 
action-potential-like test pulses indicated that the outward current carried through I r , channels 
during the action potential is mom than 10 times greater than through Irs channels (37). These 
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results agree well with the failure to increase ventricular and Purkinje fiber APD by blocking 
Iks, while Ikt block caused marked lengthening. 
Because we found Irs to have little role in normal action potential repolarization, we also 
examined its possible role when APD was artificially increased. In these experiments we tested 
the effects of both L-735,821 and chromanol 293B in dog ventricular papillary muscle action 
potentials, lengthened pharmacologically by exposure to 1 pM/1 E-4031 (to block Irt) and 1 
pg/ml veratrine (a recognised sodium channel agonist). While pacing continuously with BCL 
of 1000 ms, recordings were taken in every 5 minutes after initiating superfiasion with 1 gM/1 
E-4031 + 1 pg/ml veratrine until a "quasi" steady-state was attained (Fig. 15.). Then, in the 
continued presence of E-4031 and veratrine that pharmacologically lengthened APD, the 
effects of Irs block were examined by either applying 100 nM/1 L-735,821 or 10 pM/1 
chromanol 293B. L-735,821 markedly lengthened APD under these conditions from 385.5 ± 
25.2 ms to 442.1 ± 32.3 (p < 0.01, n = 7) (Fig. 15.). This effect was in sharp contrast to the 
negligible effect of L-735,821 on normal APD (Figs. 11., 13 ). Comparable effects on APD 
were obtained with chromanol 293 B in the continuous presence of E-4031 and veratrine (APD 
was 366.1 ± 13.1 ms before chromanol 293B versus 429.5 ± 23.5 ms after its addition, p < 
0.01, n = 8). These results indicate that the effect of IRs block on APD is substantially increased 
when APD is abnormally lengthened. In accordance with these results, currents measurements 
showed that when the duration of the rectangular or action-potential-like test pulse was 
increased, Irs was more fully activated (37). 
Firure 15. Effect of 100 nM/1 L-
735,821 on dog ventricular 
action potentials recorded in the 
presence of 1 pM/1 E-4031 and 1 
pg/ml veratrine. Panel A. The 
time course of a representative 
experiment. At 0 minute 1 pM/1 
E-4031 and 1 pg/ml veratrine 
were added and measurements 
were taken in every 5 minutes 
until a "quasi" steady state was 
achieved Then 100 nM/1 L-
735,821 was added to the bath in 
the continuous presence of E-
4031 and veratrine. The relation 
prior to addition of L-735,821 was fitted by the following equation (Y = A + B exp (-X/C)) to 
estimate the time-dependent changes that would have occurred in the absence of the Irs 
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blocker (solid line) so that the magnitude of its effect at 140 min is indicated by the arrow. 
Panel B. Representative action potentials recorded at baseline (0 min), after exposure to E-
4031 and veratrine alone (70 min), and following addition of L-735,821 (130 min). Panel C. 
Comparison of the effect of L-735,821 on "short" (open bars) and on "long" (filled bars) dog 
ventricular action potentials, respectively recorded in the absence or presence of E-4031 and 
veratrine. Small asterisks represent significant changes from baseline measurements (i.e., at 0 
min). Bold asterisk represents significant changes between the bars (p < 0.01 in both cases). 
Means ± SEM are shown. 
To further examine whether Irs block lengthens APD and increases QT interval, the effects of 
chromanol 293B (1 mg/kg i.v.) and d-sotalol (1 mg/kg i.v.) in anaesthetised dogs were also 
examined. In agreement with our in vitro observations, chromanol 293B did not significantly 
affect QTc interval, while d-sotalol markedly legthened it (37). 
Our results indicate that in contrast to specific I& bolckers, specific inhibitors of Iks do not 
lengthen APD in either type of cardiac tissues. However, when APD is abnormally lengthened 
by other means, the effect of selective Irs blockers on repolarization increases substantially 
resulting in a considerable prolongation of the ventricular muscle APD. 
4. Discussion 
4.1. Electrophysiological effects of different antiarrhythmic agents 
One of the goals of the present study was to investigate the in vitro cellular 
electrophysiological mechanisms of various antiarrhythmic drugs that act by lengthening the 
cardiac repolarization. Examing the effect of almokalant, cibenzoline and chronic amiodarone 
treatment in isolated dog right ventricular trabecular muscle it was found that all three drugs 
prolonged significantly ERP at 1 Hz stimulation frequency, which effect may be expected to be 
favourable in the management of ventricular reentry-type tachycardia. As for the impulse 
conduction time, the three agents proved to affect it in different manners. Almokalant did not 
change it at any of the stimulation frequencies applied and this is in concordance with earlier 
findings (39, 40) and indicates that this agent has no influence on the sodium channels. 
Amiodarone and cibenzoline increased conduction time in a rate-dependent fashion, suggesting 
the use-dependent inhibition of the sodium channels. Figures 1/A and B show, however, that 
while amiodarone depressed impulse conduction significantly only at high stimulation 
frequencies, i.e. this effect is only evident during tachycardia and at early extrasystoles, without 
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affecting conduction at normal heart rate, cibenzoline acted to lengthen conduction time at 
both slow, physiological and fast stimulation frequencies. This effect seems to be undesirable 
from the therapeutic point of view, since the depression of impulse conduction at normal heart 
rate can increase the occurance of proarrhythmia. On the basis of the results of our 
experiments it can be establish that cibenzoline markedly reduced the ERP shortening effect of 
cromakalim (Fig. 2.), suggesting the inhibition of the ATP-sensitive potassium channels that 
play an important role during cardiac ischaemia. It is now generally accepted that IK-ATP is 
responsible for the action potential shortening that occurs in heart muscle during metabolic 
blockade (41). These channels were characterized by a pronounced blockade of channel 
activity when millimolar concentration of ATP is present in the cell and they open when the 
cytosolic ATP level decreases below a critical threshold, resulting in the efflux of intracellular 
K+ and in the increase of extracellular K+ concentration. These changes induce the shortening 
of APD of myocytes in the ischaemic area and they also inhibit the speed of impulse 
conduction. These in turn can set the stage for reentry-type arrhythmias. In our experiments 
cibenzoline inhibited the ATP-sensitive potassium channels activated by cromakalim and this 
finding is in agreement with the literature (42), suggesting that therapeutic concentration of 
cibenzoline, that can be characterized as a Class IA drug, is effective in attenuating both 
intracellular potassium escape and the proarrhythmic, APD abbreviating effect of ishemia (43). 
It is generally accepted that Class IA drugs block also Ik (43), thus the question may arise as to 
whether the inhibition of cromakalim-induced ERP shortening caused by cibenzoline occurred, 
at least in part, via the blockade of IK. This possibility, however, is not probable since 
almokalant that is a specific blocker of Ik failed to influence the ERP shortening effect of 
cromakalim. The theapeutical role of the pharmacological modification of ATP-sensitive 
potassium channels remains to be clarified. On one hand, their inhibition can be advantageous 
in the protection against reentry-type arrhythmias, on the other hand however several 
evidences proved that the opening of these channels and as a consequence the shortening of 
the action potential can serve as an important protective mechanism for the ischaemic 
myocardium. This is because the shorter the APD, the less Ca** can enter the cell and this 
results in a decrease in contraction which is the major mechanism consuming ATP. Therefore, 
activation of IK-ATP prevents further depletion of ATP and protects the cell from irreversible 
impairment of its energy metabolism (41). In the light of the above it can be concluded that to 
decide wether the inhibitiory effect of cibenzoline on the cromakalim-induced ERP shortening 
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should be considered as a favourable antiarrhythmic mechanism or rather as an undesirable 
action that predispose to further injuries, needs further investigations. 
Our findings are in agreement with the literature (13,39,42), and indicate that there are 
important differences between antiarrhythmic drugs known to prolong repolarization. These 
differences may have important implication during treatment of cardiac arrhythmias with the 
above agents. 
The failure of the long-term antiarrhythmic therapy with Class IC and III agents shifted the 
interest toward amiodarone, a drug which seems to reduce postinfarction mortality (44). 
Amiodarone is a widely used old antiarrhythmic drug. Singh and Vaughan-Williams observed 
first the lengthening of APD after chronic treatment with the drug for 6 weeks in the rabbit 
(45). Since this discovery amiodarone has been termed a Class III antiarrhythmic drug. Later it 
was found that under acute conditions the drug use-dependently blocked Vmax and the inward 
sodium current (29,46). It was also reported that amiodarone suppressed the inward calcium 
current (47). It is now clear that amiodarone is not a "pure" Class III drug, but it has multiple 
actions including blockade of the a - and P-adrenoreceptors (48). The most characteristic 
feature of the electrophysiological effects of amiodarone is that the action of the drug differs 
markedly after acute and chronic administration (49). On the basis of earlier experiments it can 
be expected that the cardiac electrophysiological effects of chronic amiodarone treatment are, 
at least partly, due to the formation and accumulation of an active metabolite, N-
desethylamiodarone in the plasma and tissues (27). However, the mechanism of the effect of 
chronic amiodarone treatment seems to be more complex. Singh and Vaughan-Williams , as 
early as in 1970, observed the effect of long-term amiodarone treatment on thyroid function 
(45). Later it was demonstrated that experimental hypothyreodism attenuated the 
repolarization lengthening effect of chronic amiodarone treatment (50). These results suggest 
that the effects of long-term amiodarone treatment, as well as some of the serious side-effects 
accompanying it, are mediated, at least partly, via thyroid action (51). In this study the effects 
of the active metabolite, N-desethylamiodarone and a novel derivative of amiodarone lacking 
the iodine substituents, dronedarone, were characterized and compared with those of 
amiodarone in dog papillary muscles and Purkinje fibers. 
The findings were as follows: (A) In Purkinje fibers, 10 pM/1 desethylamiodarone produced 
significant shortening in both APDso and APD90 at BCL of 1000 ms, and it also shortened 
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APDgo at different constant cycle lengths and at abrupt changes in stimulation cycle length as 
well. (B) Also in Purkinje fibers, the drug induced use-dependent depression of Vmax with a 
recovery time constant of x = 341.85 ms that appears to be similar to that of amiodarone. (C) 
In ventricular muscle the drug exerted moderate use-dependent depression of Vmax without 
changing the APD and other electrophysiological parameters. (D) 10 pM/1 dronedarone, the 
recently developed iodine-free amiodarone analog, was also found to abbreviate significantly 
APD in Purkinje fibers, but not in ventricular muscle. (E) Similarly to desethylamiodarone, also 
dronedarone exerted use-dependent block of Vmax. 
It is well-known that APD in Purkinje fibers is normally longer than that in ventricular muscle. 
Therefore, the observed differential effect of both desethylamiodarone, dronedarone and 
amiodarone on the changes in APD (i.e. a marked shortening of the Purkinje fiber APD 
accompanied by no change of the APD in ventricular muscle) may contribute to an overall 
electrical stability in the heart and may possibly constitute an antiarrhythmic mechanism for the 
acute termination of cardiac arrhythmias. 
The use-dependent effect on Vmax (i.e. the largest depressant effect occurred at the shortest 
stimulation cycle length applied) found with both compounds as well as with amiodarone is 
only evident in depolarized tissue, and at high stimulation frequency (during tachycardia) or at 
early extrasystoles, without significantly affecting conduction of the action potentials at normal 
heart rate (Class I/B effect) (29). These features might be responsible not only for the 
antiarrhythmic efficacy, but also for the relative safety of these drugs in clinical settings. 
In conclusion, our results suggest that the electrophysiological effects of both 
desethylamiodarone and dronedarone are different in cardiac Purkinje and ventricular muscle 
fibers, and similar to those observed with the parent compound amiodarone. Furthermore, it 
was found that despite its lack of iodinated substituents, dronedarone exerts similar acut 
electrophysiological effects to those of amiodarone, and this finding could account for its 
promising role in the treatment of ventricular arrhythmias. 
Ambasilide is a new investigational antiarrhythmic agent, recently synthesized and being 
examined predominantly for Class i n electrophysiological properties, however multiple 
pharmacological actions of the drug are also presumed (32,33,34), making ambasilide to seem 
to share striking similarities with amiodarone in several respects. That amiodarone is uniquely 
effective in a wide variety of arrhythmias and shows very little propensity to produce TdP, 
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provides the basis for investigating the in vitro rate-dependent electrophysiological properties 
of 10 and 20 pM/1 ambasilide in canine Purkinje and ventricular muscle fibers. Our findings 
showed that the main effect of ambasilide is to lengthen APD90, (a Class III antiarrhythmic 
action) in both types of tissues and in both concentrations that have no effect on the Vmas 
when the fibers are stimulated at CLs longer than 700 ms (Table 1., Fig 3.). However, the drug 
exerted a differential effect on APD50 in the two types of preparations: in Purkinje fibers 
ambasilide shortened the phase 2 of the action potential while it prolonged phase 3, whereas 
both phases were prolonged in ventricular muscle. Several studies have indicated that the 
marked prolongation of APD50 (phase 2) in Purkinje fibers at long CLs might contribute to the 
development of EADs and triggered activity, and thus sets the stage for a variety of reentrant 
arrhythmias, including torsade de pointes (52). The effects of ambasilide proved to be different 
from those of pure Class HI agents: the lack of a significant lengthening (in 10 pMZL) or even 
a decrease of APD (in 20 pM/L) in the plateau phase of the Purkinje fibers were observed 
(Table 1., Fig. 3.), which is probably due to the inhibitory effect of the drug on the slowly 
inactivating (53) or "window" sodium current (54), and as a consequence may reduce the 
probability for the development of EADs and triggered activity. There was also a difference in 
the effects on APD90 in Purkinje fibers versus those in ventricular muscle when the stimulation 
frequency was changed. Most drugs with Class ID action prolong APD more at slower rates, 
producing little or no change at fast rates. This phenomenon, termed reverse use-dependence 
(55), is particularly evident in M cells and Purkinje fibers due to the preferential response of 
these cell types to agents that prolong APD (15). This feature of most Class i n drugs can 
seriously limit their antiarrhythmic efficacy by compromising their ability to prolong APD and 
refractoriness when most needed, i.e. during tachyarrhythmia. In addition, it also contributes 
importantly to the proarrhythmia caused by most Class HI agents because the dramatic 
prolongation of M cells and Purkinje fibers at slow rates leads to a marked increase in the 
TDR, setting the stage for a variety of reentrant arrhythmias (56,57). Our data indicate that in 
ventricular muscle both concentrations of ambasilide produced a fairly similar prolongation of 
the APD90 at all rates and therefore did not display reverse use-dependence (Fig. 4.). Although 
in 10 pM/1 the APD prolonging effect of the drug proved to be clearly reverse use-dependent 
in Purkinje fibers, this effect was moderate after applying the higher concentration of 
ambasilide (Fig. 4.). Based on this observations, it can be expected that ambasilide would be 
less proarrhythmic than both the conventional and the recently developed, newer pure Class III 
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compounds. In this context it would also be of interest, however, to evaluate the effect of the 
drug also on M cells. Due to the inhibitory effect of the drug on both I& and In3, it is likely that 
an increase in the concentration can induce a shortening of the APD of M cells, as does 
amiodarone in Purkinje fibers (26), resulting in a decrease of the TDR. 
These findings of the present study in ventricular muscle are consistent with the results of 
former studies in guinea pig (58), dog (32) and human ventricular muscle (59) that have also 
shown the lack of reverse use-dependence in the action potential prolonging effect of the drug. 
This feature of ambasilide could be of particular importance in the development of 
antiarrhythmic therapy and was suggested to be due to the block of Ikt and other repolarizing 
currents such as Iks (58), and, in atrial tissue It0 (transient outward current) and 1» (sustained 
outward current) (33,34). 
The effect of ambasilide on the rate-dependent depression of Vmax was also studied. Although 
even the higher concentration of the drug failed to produce a significant change in Vmax at BCL 
of 1000 ms (Table 1.), thereby suggesting no inhibitory action on fast sodium channels at 
normal heart rate, at higher stimulation frequencies, however, a marked frequency-dependent 
depression of Vmax was observed in ventricular muscle preparations after the application of 
both concentrations (Fig. 5/A). The use-dependent effect on Vmax suggests depression of the 
inactivated fast sodium channels, and correspond with Class I/B effect (60). The findings about 
the use-dependent effect on Vmax are in accord with the results of Takanaka et al. (32), who 
also demonstrated that ambasilide exerts inhibitory effect on the fast sodium channels at fast 
stimulation frequencies in dogs. 
Examining the effect of 20 pM/1 ambasilide on the recovery charasteristics of Vmax in 
ventricular muscle, we indeed found that ambasilide depressed Vmax at diastolic intervals 
shorter than about 1 s, (the recovery time constant of the drug was calculated to be x = 1082.5 
± 205.1 ms, n = 6). This value appears to be close to the time constant of Class I/B agents 
(61), and definitely faster than that of Class I/A and Class I/C compounds (60). The onset 
kinetics of Vmax block induced by ambasilide in this study was found to be intermediate 
between that reported of Class 1/B and Class 1/C antiarrhythmic drugs (35,61) and similar to 
that repoted of dispyramide (61). As far as we know, this is the first study demonstrating the 
effect of ambasilide on the recovery and onset kinetics of Vmax block (Fig. 6.), which may serve 
as a basis for its classification. 
Besides depressing Vmax, ambasilide also produced a marked increase in the conduction time 
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(CT). This refers to the deceleration in the speed of impulse propagation, which effect is also 
related, at least partly, to the blockade of the fast sodium channels. Similarly to the inhibition 
of Vmax, this action of ambasilide was also manifested at fast rates, ie. at short CLs (Fig. 5/B). 
On the basis of these findings, the drug can be characterized by relatively rapid offset kinetics 
from the fast sodium channels, a property which can be considered probably less proarrhythmic 
than the EC type Vmax depression caused by flecainide and encainide, i.e. drugs involved in the 
CAST study (6). 
In this context it is noteworthy to summarize the similarities found between ambasilide and 
amiodarone in several aspects. 1. Despite inducing considerable prolongation in the time for 
ventricular repolarization amiodarone produces a low incidence of torsade de pointes, a feature 
that might be attributed to its frequency-independent lengthening effect on APD. In this regard 
our findings showed, in consistence with previous studies (32,62), that at least in the canine 
ventricular muscle, ambasilide does not exhibit reverse use-dependence concerning 
repolarization. 2. The action of ambasilide resembles the effect of treatment with amiodarone, 
insofar as it either abbreviates phase 2 of the Purkinje fiber action potential (27) or produces 
markedly less prolongation of APD50 in Purkinje fibers than in ventricular muscle (25), the 
consequence of which is a reduction in the probability for development of EADs and triggered 
activity. 3. Both ambasilide and amiodarone possess important Class EB type sodium channel 
blocking activity (29), especially under conditions in which sodium channels are partially 
inactivated. In all these respects, amiodarone and ambasilide differ markedly from other 
conventional and newer Class III antiarrhytmic agents and neither of them fit well into the 
conventional antiarrhythmic classification scheme (63). The similarity found in all the above 
actions of ambasilide and those of amiodarone suggests that because of its advantageous, 
"multifaced" electrophysiological profile, ambasilide may be a promising drug candidate for 
antiarrhythmic drug therapy. 
4.2. Electrophysiological and pharmacological heterogeneity within the ventricle: the 
role of M cells 
In this study the cellular electrophysiological and pharmacological properties of M, 
endocardial, epicardial and Purkinje cells of the dog left ventricle were examined and 
compared. We confirmed the existence of M cells in the canine left ventricle described earlier 
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(16). In addition, we also revealed important differences in certain action potential parameters 
of M cells, which were not previously mentioned by others. It was also demonstrated in the 
present study that M cells differ from Purkinje fibers in some aspects which were not obvious 
from previous investigations; 1. the early portion of the APD restitution curve in M cells is 
more similar to that of endocardial and epicardial cells than to Purkinje fibers (Fig. 9.), 2. the 
potential range of the plateau phase in the M cell action potential is also more similar to that of 
endocardial and epicardial cells than to Purkinje fibers (Fig. 7.), 3. the pharmacologic response 
of M cells to TTX or pinacidil resembles more the endocardial and epicardial cells than the 
Purkinje fibers (Fig. 10.). 
In recent years a growing number of studies have stressed the importance of diversity within 
the ventricles of the heart attaching great significance to differences in the electrophysiological 
characteristics and pharmacological responsiveness of M cells located in the deep structures of 
canine (16,19), guinea pig (64), rabbit (65), and human ventricles (66). These cells are 
distinguished mainly by the ability of their action potential to prolong disproportionately to the 
other cell types with slowing of the stimulation rate and their greater sensitivity to agents and 
interventions that prolong APD. Besides the marked rate-dependent change of APD in M cells, 
the high Vmax value of their action potential resembles also those observed in Purkinje fibers 
(16). However, M cells show no phase 4 depolarization, not even in the presence of 
catecholamines and low potassium concentration. Therefore it was concluded that M cells 
display characteristics common to both myocardial cells (spike and dome morphology, absence 
of phase 4 depolarization) and Purkinje fibers (higher Vmax, steeper APD-rate relation). Our 
findings further delineate the distinctions among cells spanning the wall of the canine left 
ventricle. 
Action potentials recorded in the four tissues of the canine ventricle exhibit marked differences 
in morphology (Fig. 7.). Prominent among these is the presence of an expressed phase 1 in 
epicardial, M and Purkinje cells but less in endocardial fibers. Aside from differences in the 
early phases of the action potential, a significant distinction exist among the four cell types with 
respect to phase 3 repolarization, the result of which is a progressive prolongation of APD in 
M cells and Purkinje fibers relative to epicardial and endocardial cells with the slowing of rate. 
Also, Purkinje fibers displayed plateau phase at a more negative potential range than the other 
cell types studied. Our data concerning action potential characteristics are in agreement with 
those of Sicouri & Antzelevitch (16), who described similar results previously. In addition, we 
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also could reveal important differences in certain action potential parameters of M cells which 
were not described earlier by others, namely the distribution of V M A X and action potential 
amplitude values reflecting probably the inhomogeneity of the fast sodium current in these cells 
(Table 3.). It has to be noted that action potentials recorded in the two groups of cells 
displayed characteristics of M cells, i.e. they possessed the ability to prolong disproportionately 
APD when compared with epicardial and endocardial fibers in response to a slowing of the 
stimulation rate. To our knowledge, the present study is the first to demonstrate that 
concerning the magnitude of V M A X 5 which probably reflects the intensity of the fast sodium 
current, M cells are not uniform. 
The rate dependence of APD is the major feature differentiating M cells from the other two 
cell types present within the ventricular wall and making them more similar to Purkinje fibers. 
Examing the steady-state rate-dependence of APD in the four types of tissue we found, in 
concordance with the literature (16), that the slope of APD-cycle length relation was clearly 
much steeper for M cells than that for epicardial and endocardial cells at all rates of stimulation 
except for BCLs shorter than 500 ms, while it was remarkably similar to that observed in 
Purkinje fibers, which displayed an even more pronounced APD rate relation than M cells. 
There were no significant differences in steady-state APDs at all stimulation rates between 
endocardial and epicardial cell preparations. 
The greater prolongation of the M cell response could give rise to a prominent dispersion of 
repolarization and refractoriness between the cells in the M region and cells in other parts of 
ventricular myocardium, as well as a dispersion of repolarization between the myocardium and 
the His-Purkinje system (67) as stimulation rate is slowed. This heterogeneity provides an 
important substrate for a variety of reentrant arrhythmias, including intramural reentry and 
TdP, and regarding that M cells are estimated to constitute at least 40% of the total ventricular 
myocardial mass (68), their possible role in arrhythmogenesis is especially of great significance. 
Based on the available data on TDR within the ventricle, Antzelevitch suggested (69) that 
since M cells may be the most abundant cell population in the ventricles and may represent the 
true working myocardial cells of these cardiac chambers, they may have evolved for the 
purpose of improved pump efficacy especially at slow rates at which more enduring 
depolarizations permit longer and more efficient contractions. Epicardium and endocardium 
may have developed to prevent dramatic prolongation of the M cell action potential and the 
development of afterdepolarizations. Accordingly, removal of a section or infarction of a 
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segment of epicardium or endocardium would be expected to lead to an increase of the QT 
interval and QT dispersion secondary to a prolongation of the M cell APD (70,71). In patients 
treated with drugs exhibiting Class III antiarrhythmic actions or in those with the congenital or 
acquired long QT syndrome, these effects of infarction to transiently increase QT and QT 
dispersion might be even more amplified (56). The implication of this might be an arrhythmic 
substrate capable of maintaining both monomorphic and polymorphic arrhythmias. 
The remarkable distinction between the restitution of APD in M cells and Purkinje fibers (Figs 
8.,9.) also represent an important electrophysiological difference between the two types of 
fiber, which has not been described yet. In order to explore the ionic nature of the differences 
in the restitution of APD among the four ventricular tissue types, however, further research is 
required, with more direct experimental methods like the patch-clamp technique. 
It has been already reported that the four distinct cell types of the ventricles show different - in 
some cases opposite - responses to a wide variety of pharmacological agents (14,26,72,73,74, 
75,76,77,78). Although the electrophysiological actions of sodium and calcium channel block 
and the activation of ATP-sensitive potassium channels have been well characterized in 
Purkinje and endocardial preparations (54,79,41), in vitro investigations of the same 
interventions are limited in epicardial (14,72,73,79) and especially in M cells (80). Therefore, 
we compared the pharmacological response of the four tissue types to the sodium channel 
blocker tetrodotoxin, calcium channel blocker nifedipine, and ATP-sensitive potassium channel 
activator pinacidil. Our results show that TTX shortened APD in both M cells and Purkinje 
fibers significantly, whereas no significant changes in APD were observed in epicardium or 
endocardium after application of this agent. Despite the qualitatively similar effect of TTX on 
M cells and Purkinje fibers, it has to be emphasised that the degree of APD abbreviation was 
more accentuated in Purkinje fibers than in M cells, suggesting a weaker contribution of the 
sodium current to repolarization in M cells than in Purkinje fibers, findings making M cells to 
be more akin to epicardial and endocardial cells. The organic calcium channel blocker 
nifedipine was found to reduce APD in all the four tissue types significantly without displaying 
remarkable difference with respect to the extent of abbreviation in any of the preparations. 
Our data about the effects of pinacidil that is known to augment IK-ATP in cardiac tissues (81) 
show that the relatively high concentration (10 pM/1) of the drug caused a significant 
abbreviation of repolarization in all the four tissue types. Nevertheless, APD was shortened 
more excessively in Purkinje fibers than in ventricular muscle fibers. Thus we can conclude that 
38 
the pharmacological response to tetrodotoxin and pinacidil in M cells resembles more that in 
the epicardial and endocardial cells than that in the Purkinje fibers (Fig. 10.). 
In conclusion, our results provide further important evidence in support of the existence of M 
cells in the deep subepicardium of the canine ventricle and indicate that there are significant 
electrophysiological as well as pharmacological differences between M cells and Purkinje cells. 
The establishment of complete profiles of the pharmacological responsiveness of the four cell 
types in the ventricle may narrow the gap that currently exists in this area and should bring us a 
step closer to a more definitive, evidence-based and less empirical approach in the medical 
management of cardiac arrhythmias. 
4.3. Pharmacological modulation of the delayed rectifier potassium current in dog 
ventricular muscle and Purkinje fibers 
Iks and Ikt are both generally accepted as having important roles during normal action 
potential repolarization (18,82). The assumed importance of Iks is also underscored by the fact 
that the relative small density of this current was proposed to be the main reason for the longer 
repolarization observed in M cells relative to epicardial and endocardial cells (19). It has been 
known for long that specific I& blockers (e.g. d-sotalol, dofetilide, E-4031) greatly lengthen 
cardiac APD (21,83) and thus provide antiarrhythmic benefit by increasing refractory wave 
length. However, these drugs also increase risk for development of bradycardia-induced 
polymorphic ventricular tachyarrhythmias (84). The APD increase induced by selective Ikt 
blockade displays reverse use-dependency (55) that is especially pronounced in Purkinje fibers 
(20). In contrast with Ikt blockers, however, on the basis of previous data obtained in the 
guinea pig (21), selective Irs block has generally been assumed to increase APD and 
refractoriness in frequency-independent manner, possessing thereby better safety than 
currently available Class HI compounds. Accordingly, development of such drugs are expected 
to offer favourable new options for antiarrhythmic drug therapy. However, selective IRS 
blockers have only recently been available (22,23).Recent studies using canine ventricular 
myocytes have revealed considerable species differences in the properties of IR (38) and the 
important question therefore arise as to how findings obtained from the guinea pig may be 
extrapolated to other mammalian species. With the development of specific IRS blockers, it has 
become possible to directly determine the effect of IRS on APD, and thus our aim was to 
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establish the role of this current in producing normal cardiac action potential repolarization in 
dog by comparing the magnitude and extent of changes in the first instance in ventricular 
muscle and Purkinje fiber APD produced by selective block of Irt and Irs. Our presumption 
was that since Irs activation starts at around 0 mV (37) and this voltage is more positive than 
the normal Purkinje fiber action potential plateau voltage (Fig. 7.) (36), Irs block should not be 
expected to increase Purkinje fiber APD, but only that of ventricular muscle, due to the fact 
that in this latter type of cells the action potential plateau voltage is more positive (« +20 mV), 
allowing Irs to be substantially more activated, and resulting in a marked increase of APD after 
the blockade of this current. On this basis specific Irs blockers may produce antiarrhythmic 
benefit by decreasing enhanced dispersion in repolarization between ventricular muscle and 
Purkinje fiber, and thus limiting arrhythmogenesis. Our results supported this assumption only 
in part, since in addition to Purkinje fiber also in papillary muscle preparations both chromanol 
293B and L-735,821, purportedly selective Irs blockers, failed to markedly lengthen APD (Figs 
11.,13.). Equivalent concentrations of both compounds, however, substantially blocked Irs in 
isolated dog ventricular myocytes (37). Adenylcylase stimulation by forskolin, known to 
increase Irs (85), did not considerably alter the chromanol 293B or L-735,821 induced change 
in APD in dog papillary muscle (Fig. 14.). In contrast, E-4031 and d-sotalol (recognized Irt 
blockers) markedly lengthened dog ventricular muscle and Purkinje fiber APD (Figs 12., 13.). 
In agreement with these in vitro results, QTc was increased in vivo by d-sotalol but not by 
chromanol 293B in anaesthetised dogs. However, in papillary muscle preparations where APD 
was prolonged by E-4031 and veratrine, both chromanol 293B and L-735,821 increased 
repolarization considerably (Fig. 15.). 
The few published studies that have examined the effect of Irs on cardiac APD are rather 
contradictory. Bosch et al. (86) for example, using the whole-cell patch-clamp technique in 
single isolated guinea pig and human myocytes, reported that APD increased following 
chromanol 293B exposure. In that study, a relatively small number of cells (5-8 cells) were 
examined and measurements in the absence or presence of chromanol 293B were made in 
different myocyte groups. It is also notable that APD measurements in single myocytes 
inherently show enormous beat-to-beat variability that makes identification of the effects of 
selective ion channel block on action potential configuration uncertain, at best. Nevertheless, 
our results using standard intracellular microelectrode recordings in dog papillary muscles 
agree, in part, with those of Schreieck et al. (87) in guinea pig papillary muscle; i.e., 10 pM/1 
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chromanol 293B did not lengthen APD in the absence of forskolin. However, in dog papillary 
muscle, we found no increase in APD after adenylcyclase stimulation as Schreieck et al. (87) 
did, following isoproterenol exposure in guinea pig. This deviation from the findings of 
Schreieck et al. (87) might be due to species differences. Certainly Irs amplitude is relatively 
large in the guinea pig (18) compared to dog and other species (38). In addition, we applied 1 
pM/1 forskolin while Schreieck et al. (87) used 100 nM/1 isoproterenol to activate 
adenylcyclase. Because other currents are also modulated by cAMP (e.g., Ica and Ici) that also 
affect APD (88), the observations in the two studies may not be directly due to Irs block. Irs 
block, in our study, produced substantially different effects in multicellular dog cardiac 
Purkinje fiber strands than in the paper of Cordeiro et al. (89), who reported marked APD 
lengthening in isolated rabbit cardiac Purkinje fiber cells after superfiision with only 20 nM/1 L-
735,821. The reason for this discrepancy in findings is unknown, although the action potential 
plateau voltage in the rabbit Purkinje fiber cells illustrated by Cordeiro et al. (89: Fig. 9.) is 
approximately -20 mV, while in the same study (89: Fig. 11.) these authors show that 
activation of the L-73 5,821 sensitive current (presumably Irs) occurs at voltages positive to 0 
mV. These facts make it unlikely that the observed increase in APD reported by Cordeiro et al. 
(89) was due to Irs block. The effects of d-sotalol and E-4031 on Purkinje fiber APD in our 
study are in excellent agreement with those previously published (18,84). 
Prior to our report (37), Irs was believed vital to control normal cardiac action potential 
repolarization (19,82). In addition, based on experiments performed in guinea pig ventricular 
myocytes, selective Irs block was believed to increase APD without producing undesired, 
reverse use-dependent APD lengthening characteristic of Irt block (21). This expectation was 
based on the findings that Irs deactivates slowly in guinea pig so that reduction in outward 
current due to its block would be expected to be greater at fast heart rates (short diastolic 
intervals) than at slow heart rates or long intervals between subsequent action potentials. More 
recently, however, both in dog ventricular myocytes (38) and human ventricular myocytes 
(90), Irt has been demonstrated to deactivate slowly while Irs deactivates relatively rapidly. 
This is quite unlike the situation in the guinea pig and brings the speculation originally 
presented by Jurkiewicz & Sanguinetti (21) into question. Our finding that Irs block does not 
remarkably increase APD in either normal dog ventricular muscle or Purkinje fibers over a 
wide range of stimulation frequencies directly contradicts the 1993 Jurkiewicz & Sanguinetti 
hypothesis, as well as the hypothesis of Liu & Antzelevitch (19) who showed in isolated dog 
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ventricular myocytes that M cells express a lower density of Irs channels than do 
subendocardial or subepicardial cells. On this basis these latter authors postulated that the 
longer M cell APD was due to less repolarizing current flowing through Irs channels. Our 
present data, however, indicate that an 80 - 100% Irs block failed to substantially lengthen 
APD in dog subendocardial papillary muscle; i.e. substantial Irs block did not cause 
subendocardial cells to resemble M cells. Thus, differences in other membrane currents, such as 
sodium window currents (or slowly inactivating In3) density for example (80), may help 
account for the differences in M cell and subendocardial ventricular muscle cell action potential 
configurations. 
Although Irs may have little role in normal action potential repolarization, it likely plays a vital 
role when cardiac APD is abnormally lengthened by other mean (e.g., by reductions in Ir, or 
Iri or increases in INa or ICa). This speculation is supported by our experiments where APD was 
substantially increased by pharmacological means of augmenting inward (IN3) and decreasing 
outward (Irt) currents (Fig. 15.) Also our estimation of Irt and Irs, when the duration of the 
rectangular or action-potential-like test pulse was increased, showed that Irs was more fully 
activated than during the normal action potential (37). Thus, Irs is expected to limit excessive 
APD lengthening when repolarization is abnormally lengthened. As such, pharmacological 
block of Irs might be expected to have severe detrimental consequences when this protective 
mechanism is eliminated. For example, if repolarization is excessively lengthened due to drug 
induced Irt block, hypokalemia, genetic abnormality, or bradycardia, the subsequent increase 
in APD would favour Irs activation and provide a negative feedback mechanism to limit further 
APD lengthening. Without such a mechanism, excessive APD lengthening might lead to 
enhanced regional repolarization dispersion (57) and increase propensity for development of 
EAD associated with TdP induction. Such a role for Ir, in limiting excessive APD lengthening 
was first postulated by Ito and Surawicz (91), and if Irs plays such a role, antiarrhythmic agents 
producing nonselective block of Ir, and Irs (e.g., quinidine and azimilide) might be associated 
with a greater proarrhythmic risk than "pure" (selective) Irt blockers (e.g., sotalol and 
dofetilide). 
In conclusion, this study indicates that in normal dog ventricular muscle Irs plays a minor role 
in control of APD. This current, however, could provide an important means of limiting 
excessive APD lengthening when action potentials are increased beyond normal by other 
means. 
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